BRAINSTORM CELL THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5201 USD | +0.79% |
|
+14.06% | +90.51% |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Other Biotechnology & Medical Research | +0.79% | +14.06% | +90.51% | -81.16% | -86.63% | 35.26M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BCLI Stock
- Charts Brainstorm Cell Therapeutics Inc.
- Comparison Chart
